Cyprus Mail on MSN

Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Vaccine makers Pfizer PFE.N and BioNTech 22UAy.DE halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to ...
Fierce Pharma

Pfizer looks to jump start Elrexfio with topline win in second-line myeloma

Nearly three years after the FDA approved Pfizer's bispecific antibody Elrexfio as a late-line treatment for patients with ...

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer said on Wednesday its drug Elrexfio met the main goal in a ​late-stage trial that tested the blood cancer ‌treatment ...
NBC Washington

Pfizer, BioNTech Say Trial Data Shows COVID-19 Vaccine More Than 90% Effective

Pfizer and BioNTech announced Monday their coronavirus vaccine was more than 90% effective in preventing COVID-19 among those without evidence of prior infection, hailing the development as “a great ...
6abc News

Pfizer submits initial data to FDA on its COVID-19 vaccine for kids 5-11

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...